Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy
嗜酸性粒细胞作为一线免疫检查点抑制剂联合疗法治疗转移性肾细胞癌患者治疗相关不良事件的预测标志物
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-08767-9
Kawada, Tatsushi; Katayama, Satoshi; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Komura, Kazumasa; Tsujino, Takuya; Maenosono, Ryoichi; Takahara, Kiyoshi; Nukaya, Takuhisa; Inoki, Lan; Toyoda, Shingo; Hashimoto, Takeshi; Hirasawa, Yosuke; Edamura, Kohei; Kobayashi, Tomoko; Bekku, Kensuke; Nishimura, Shingo; Iwata, Takehiro; Sadahira, Takuya; Tominaga, Yusuke; Yamanoi, Tomoaki; Yoshinaga, Kasumi; Tsuboi, Kazuma; Kobayashi, Yasuyuki; Takamoto, Atsushi; Kurose, Kyohei; Kimura, Takahiro; Azuma, Haruhito; Shiroki, Ryoichi; Fujita, Kazutoshi; Ohno, Yoshio; Araki, Motoo
